ArticleTheScientificWorldJournal2012

Sorafenib inhibits tumor growth and improves survival in a transgenic mouse model of pancreatic islet cell tumors.

Volker Fendrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.